Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Irbesartan and Ciprofibrate on Endothelial Function
NCT00350038Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hypertension (HTN) and dyslipidemia comparing Irbesartan Monotherapy with Irbesartan + Ciprofibrate (2 arms). Primary endpoint: Microvascular reactivity. Started Feb 2005; status: completed.
02
Drugs
irbesartanciprofibrate
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT00350038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350038.